- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Dr Amila Patel on How Flatiron Will Help Promote Coordination of Care, Address Physician Burnout
Clinical workflow features being implemented by Flatiron will help address both coordination of care and physician burnout, explained Amila Patel, PharmD, BCOP, technical lead, Clinical Oncology, Flatiron Health.
Clinical workflow features being implemented by Flatiron will help address both coordination of care and physician burnout, explained Amila Patel, PharmD, BCOP, technical lead, Clinical Oncology, Flatiron Health.
Transcript
How will new features in the clinical workflow help promote better coordination of care?
Collectively, that’s exactly what we’ve been aiming to do with these features. So, our visit note experience enables collaboration between the care team together by introducing real-time collaboration and auto-saving functionality. Our inbox experience is intended to be such that people are coordinating care across the care team and we’re looking to make sure this information reaches the patient and that there’s care collaboration with them.
Will these new features also impact the growing issue of physician burnout?
Yes, everything we do in in that mind set of reducing physician burnout. As a specific example, with our Flatiron Assist tool, we’re trying to make it such that providers can go directly to the regimen they know while also proving concordance with the [National Comprehensive Cancer Center] guidelines and hopefully streamlining the prior authorization process, which we know is just so burdensome for both providers and patients.
The Challenge of Addressing Drug Spend to Drive Down Total Cost of Care in EOM
October 27th 2024Stuart Staggs, vice president of transformation and shared services at McKesson, explained that oncology practices in the Enhancing Oncology Model (EOM) have a tough job driving down costs when drug costs make up a larger portion of the total cost of care.
Read More
Exploring Racial, Ethnic Disparities in Cancer Care Prior Authorization Decisions
October 24th 2024On this episode of Managed Care Cast, we're talking with the author of a study published in the October 2024 issue of The American Journal of Managed Care® that explored prior authorization decisions in cancer care by race and ethnicity for commercially insured patients.
Listen
Targeting Progression: Amivantamab’s Role in NSCLC After Osimertinib
October 24th 2024Amivantamab's role in non–small cell lung cancer (NSCLC) has been a highlight of the lung cancer space this year, with the 2 most recent approvals based on data from the MARIPOSA and MARIPOSA-2 trials.
Read More
Sarcoma Care: Biomarker Advancements Shape the Future
October 24th 2024At the regional Institute for Value-Based Medicine® event in Boston, Vinayak Venkataraman, MD, medical oncologist at Dana-Farber Cancer Institute and Harvard Medical School, was a panelist for the discussion, “Recent Advancements in Identifying Predictive Biomarkers for Sarcomas."
Read More
